Operating Cash Flow per Share: A measure of financial performance calculated as operating cash flow, expressed on a per share basis. Calculated as: Cash Flow from Operations / Weighted Average Shares Outstanding (Diluted)
Royalty Pharma PLC (RPRX) had Operating Cash Flow per Share of $2.60 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$674.14M |
|
$17.88M |
|
-- |
|
$674.14M |
|
$541.02M |
|
$133.12M |
|
$-51.63M |
|
$81.49M |
|
$116.37M |
|
$81.49M |
|
$81.49M |
|
$81.49M |
|
$116.37M |
|
$133.12M |
|
$142.14M |
|
445.06M |
|
556.90M |
|
$0.04 |
|
$0.04 |
|
| Balance Sheet Financials | |
$1.76B |
|
$16.19B |
|
$18.06B |
|
$19.82B |
|
$630.93M |
|
$8.58B |
|
$9.40B |
|
$10.03B |
|
$9.79B |
|
$8.86B |
|
$9.79B |
|
1.01B |
|
| Cash Flow Statement Financials | |
$1.45B |
|
$-707.59M |
|
$-545.82M |
|
$618.70M |
|
$811.99M |
|
$193.29M |
|
$229.06M |
|
$-448.00M |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.80 |
|
-- |
|
-- |
|
0.47 |
|
0.92 |
|
100.00% |
|
19.75% |
|
19.75% |
|
-- |
|
12.09% |
|
2.65% |
|
$743.31M |
|
-- |
|
-- |
|
-- |
|
0.03 |
|
-- |
|
21.42 |
|
4.20 |
|
0.83% |
|
0.92% |
|
0.41% |
|
0.44% |
|
$9.73 |
|
$1.33 |
|
|
Operating Cash Flow per Share |
$2.60 |